Skip to main content

Table 1 Expected cost and expected revenue of each project ($ million)

From: Pharmaceutical portfolio optimization under cost uncertainty via chance constrained-type method

Project Phase Reg Expected revenue
PC PH1 PH2 PH3
Project 1 1 7 27 126 7 191
Project 2 1 7 27 101 7 235
Project 3 5 27 127 7 14,205
Project 4 1 47 63 7 8100
Project 5 22 164 7 955
Project 6 11 75 5 744
Project 7 27 7 6043
Project 8 1 7 27 123 6 179
Project 9 26 6 5677
Project 10 27 8 13,530
Project 11 20 155 8 668
Project 12 21 164 7 1036
Project 13 27 132 9 1347
Project 14 12 140 9 1285
Project 15 3 7 32 146 7 259
\